Cornell, R., Parameswaran, H., Tang, S., Barnstead, A., Biran, N., Callander, N., … Costa, L. (2019). Real world vs. clinical trial outcomes of triple class refractory penta-exposed multiple myeloma (MM). In Clinical Lymphoma Myeloma and Leukemia (Vol. 19, pp. e115–e116). Elsevier BV. https://doi.org/10.1016/j.clml.2019.09.191

Cornell, Robert, Hari Parameswaran, Shijie Tang, Alyssa Barnstead, Noa Biran, Natalie Callander, Ajai Chari, et al. “Real world vs. clinical trial outcomes of triple class refractory penta-exposed multiple myeloma (MM).” In Clinical Lymphoma Myeloma and Leukemia, 19:e115–16. Elsevier BV, 2019. https://doi.org/10.1016/j.clml.2019.09.191.

Cornell R, Parameswaran H, Tang S, Barnstead A, Biran N, Callander N, et al. Real world vs. clinical trial outcomes of triple class refractory penta-exposed multiple myeloma (MM). In: Clinical Lymphoma Myeloma and Leukemia. Elsevier BV; 2019. p. e115–6.

Cornell, Robert, et al. “Real world vs. clinical trial outcomes of triple class refractory penta-exposed multiple myeloma (MM).” Clinical Lymphoma Myeloma and Leukemia, vol. 19, no. 10, Elsevier BV, 2019, pp. e115–16. Crossref, doi:10.1016/j.clml.2019.09.191.

Cornell R, Parameswaran H, Tang S, Barnstead A, Biran N, Callander N, Chari A, Chhabra S, Fiala M, Gahvari Z, Gandhi U, Godby K, Gupta R, Jagannath S, Jagosky M, Kang Y, Kansagra A, Kauffman M, Kodali S, Kumar S, Lakshman A, Liedtke M, Lonial S, Ma X, Malek E, Mansour J, McGehee E, Narayana S, Neppalli A, Paul B, Richardson PG, Scott E, Shacham S, Shah J, Siegel DS, Umyarova E, Usmani S, Varnado W, Vij R, Costa L. Real world vs. clinical trial outcomes of triple class refractory penta-exposed multiple myeloma (MM). Clinical Lymphoma Myeloma and Leukemia. Elsevier BV; 2019. p. e115–e116.